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Abstract
As countries move from intense malaria transmission to low transmission there
will be a demand for more sensitive tools and approaches in tracking malaria trans-
mission dynamics. Surveillance tools that are sensitive in tracking real time infectious
bites as well as infectious reservoir will be preferred to counting number of cases in
the hospital or parasite prevalence. The acquisition and maintenance of anti-malarial
antibodies is a direct function of parasite exposure, seroprevalence rates has been
used as an efficient tool in assessing malaria endemicity and confirming malaria
elimination. Plasmodium antibodies are explicit biomarkers that can be utilised to
track parasite exposure over more extensive time spans than microscopy, rapid
diagnostic testing or molecular testing and the conventional entomological inocula-
tion rate. Seroprevalence studies can therefore help monitor the impact of malaria
control interventions, especially when the parasite occurrence is low. As a result,
antibody responses to Anopheles salivary proteins or Plasmodium species may
potentially offer reliable information of recent or past exposure; recognise short-term
or gradual changes in exposure to Plasmodium infection or to estimate individual-
level exposure to infection. This book chapter will present about four studies we have
conducted across eastern and western Africa on the efficiency of salivary gland pro-
teins and antimalarial antibodies in tracking malaria transmission intensity. We hope
that these could be used as surveillance tools in malaria elimination efforts.




Since the inception of initiatives such as the Roll Back Malaria and the creation of
the UnitedNationsMillenniumDevelopment Goals (MDGs) on combating HIV/AIDS,
malaria, and other diseases in September 2000, unprecedented progress has been
made in the fight against malaria. Malaria vector control interventions such as indoor
residual spraying (IRS), the provision of insecticide-treated bed nets (ITNs) and the
use of artemisinin-based combination therapy for the prompt treatment of clinical
malaria cases has led to a decrease in the number of malaria morbidity and mortality
rates in many endemic areas in the world [1]. Globally, the rate of new malaria
infections and deaths decreased by 41% and 62% respectively between 2000 and 2015
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[2]. Despite the many interventions, malaria remains a major public health concern in
many African countries. According to theWorld health Organisation (WHO), an
estimated 229 million malaria cases were recorded in 2019 with 409,000 deaths [3].
Increasing insecticide resistance and behavioural changes by vectors that transmit
malaria parasites as well as drug-resistant parasites threaten the progress made so far.
The advances made in malaria control in many countries have in effect led to the
disease becoming more varied, leading to a new challenge of understanding the
disposition of lingering transmissions in certain populations [4]. The remedy to this
conundrum is a rigorous surveillance system with the ability to measure spatial and
temporal variations in malaria transmission accurately and efficiently. The Global
technical strategy for malaria 2016–2030 provides a comprehensive framework to
guide countries in their efforts to accelerate progress towards malaria elimination
[5, 6]. The strategy sets the target of reducing global malaria incidence and mortal-
ity rates by at least 90% by 2030 [6]. This technical strategy recognises the critical
role that surveillance plays in malaria elimination.
Malaria surveillance metrics used over the years to measure transmission include
both entomological and parasitological metrics such as parasite prevalence, clinical
cases and serological measurements which rely on host antibody responses to both
the vector and parasite antigens [4, 7].
2. The significance of malaria surveillance
Malaria surveillance deals with continually and systematically collecting malaria
specific data, analysing and interpreting such data [6]. This could be essential in the
planning, implementation and evaluation of public health practice. As part of the
Global Technical Strategy for Malaria 2016–2030, WHO has urged endemic
countries and those that have achieved elimination to strengthen their disease
surveillance in order to identify any reinfection, reemergence or resistance. Malaria
surveillance also makes available data to help all transmission settings make appro-
priate decisions regarding malaria control strategies, priorities and resource alloca-
tion. In order to achieve malaria elimination globally, surveillance is crucial because
it will provide accurate data at any point in time regarding the state of a particular
country in connection with malaria.
3. Challenges to malaria surveillance
The continuous and systematic collection, analysis and interpretation of malaria-
specific data and the use of such data in the planning, implementation and evalua-
tion of public health practice is paramount in the quest to eradicate malaria. Sur-
veillance programmes can enable resource-poor malaria-endemic countries to
prioritise populations that are most in need, re-strategize in cases where interven-
tions have not resulted in decrease in cases and appropriately respond to pockets of
outbreak cases without wasting resources. Malaria surveillance programmes should
therefore seek to identify the most affected populations, trends in incidence and
mortalities as well as the overall impact of control measures [5].
In many countries, malaria surveillance systems remain inadequate to support
the goal of elimination [8]. The intensity of malaria transmission is closely linked to
the epidemiology of the disease. Transmission intensity is often measured using the
parasite prevalence metric, which measures the proportion of the population with
detectable parasites in the blood in a given locale. The entomological inoculation
rate, malaria-positive fraction, incidence rate and deaths are other metrics used to
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measure malaria transmission intensity [9]. The 2020 world Malaria Report rightly
recognised the weak surveillance systems in moderate to high malaria transmission
countries that rely solely on parasite prevalence or clinical case reporting for sur-
veillance [3]. This greatly affects the quality of data for epidemiological studies.
Improving the scope and quality of surveillance is critical to malaria elimination.
Many malaria endemic countries use clinical case reports for surveillance due to
its ease and affordability. However, clinical case reporting has some limitations such
as the inability to measure asymptomatic infections as well as infections among
transient populations who contribute to transmission [10, 11]. Parasite prevalence
surveys are also useful in malaria surveillance, however, in cases of low transmis-
sion, large sample sizes are required before useful prevalence data can be obtained.
Other seldomly used metrics such as entomological inoculation rate is very labor
intensive and costly to implement in malaria endemic populations on routine basis,
making it less useful [12]. It is therefore critical that countries adopt surveillance
metrics such as serum anti-malarial antibody based seroprevalence surveys that can
effectively measure both high and low transmission as well as the temporal and
spatial variations in malaria transmission. Such a metric can complement the
already existing clinical case reporting and parasite prevalence surveys.
Seroprevalence is a surveillance metric used to measure the antibody markers
that are elicited by host cells in response to vectors and parasites. Measuring the
proportion of the population who are seropositive for malaria could inform the rate
of malaria transmission over time and space [13, 14].
4. Markers of malaria exposure
Measurement of serum anti-malarial antibodies is a useful marker of malaria
exposure that indicates long-term transmission potential especially if such mea-
surements are done over a period of time. This is mainly because anti-malarial
antibodies develop after repeated exposures and can persist for months to years
after infection [7, 14]. In very low transmission settings, where parasite prevalence
and entomological inoculation rate (EIR) are insensitive, serological measures offer
a way of accurately assessing endemicity and identifying focal areas of transmission
supporting the potential for elimination [7]. Evaluating serological evidence of
malaria exposure in the human population provides insight into malaria endemicity.
Seroconversion rates are related to the force of infection of malaria as reflected
through the immune responses of exposed individuals. Thus, the seroconversion
rates provide measures of malaria exposure that compare with the malaria trans-
mission intensity [14]. Different antibodies can be used in malaria intensity studies
depending on the life span of that protein and how well it is produced in low or high
endemic regions as a direct response to exposure.
IgG response to whole saliva extracts of Anopheles gambiae has been observed as
a marker of exposure to Anopheles gambiae bite, and consequently, high anti-saliva
IgG levels is a predictive indicator of malaria morbidity [15]. One protein that is
being explored is the salivary gland protein and its peptide P1. The Anopheles
gambiae salivary gland gSG6 protein and derived P1 peptide are specific to An.
gambiae and elicit specific antibody response in the human host. It is said to have
the potential to represent a general epidemiological marker of exposure of the main
Afro-tropical malaria vectorial system, Anopheles arabiensis and Anopheles funestus
up to 99% and 80% respectively [15].
Other malaria antibodies that are used in most malaria antibody studies include
circumsporozoite protein (CSP), apical merozoite antigen-1 (AMA1), merozoite
surface proteins 1 and 3 (MSP -1, MSP-3) [16, 17].
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5. Seroprevalence as malaria transmission metric for surveillance
Changes in vector exposure, parasite infections in humans and human
immunity can alter the metrics of malaria transmission. Thus, the malaria
transmission metric used to determine transmission intensity should depend on
the intrinsic variability of the metric across space and time [18]. These variations
that might go undetected by parasite prevalence can be identified with the use of
seroprevalence data, antibody density and seroconversion rates. In the era where
transmission intensity of malaria is decreasing it becomes particularly difficult to
use popular methods like the entomological inoculation rate (EIR). Thus, the use of
other serological tools based on antibody responses to parasite and vector antigens
are potentially valuable for robust transmission measurement.
Serosurveillance offers an approximation of the antibody levels elicited against
an infectious disease. Many developed countries have well established national
serosurveillance programs for different infectious diseases [19]. Serosurveillance of
malaria offers the advantage of making known active transmission in cases that
would otherwise be deemed as interrupted transmission [20]. A case example was
observed in Ghana where the parasite prevalence was well below 5% throughout the
year, whereas an equivalent seroprevalence of mosquito salivary protein gSG6-P1
and Plasmodium falciparum merozoite surface protein MSP119 were above 40%
(Figure 1) [21]. A similar observation was made in a study in Somalia where the
prevalences of MSP119 were 17.9% and 19.3% in the wet and dry seasons respec-
tively when no parasites had previously been observed [20]. A prevalence of 10%
and 50% were observed for parasite and MSP119 respectively in the uphill dwellers
of the Western Kenyan highlands, emphasising robustness of serological markers in
tracking temporal changes in vector exposure, especially in younger populations
[17]. Human immune response to Anopheles salivary gSG6-P1 varies in relation to
exposure to mosquitoes. Measuring human-mosquito contact using gSG6-P1 has
therefore been shown to be very reliable.
Seroconversion rates (SCR) which is a function of age and exposure have been
estimated using MSP119 age-specific seroprevalence. This has been used to measure
the transmission intensity of malaria and has been shown to correlate with EIR
measurements [7, 22]. Age-specific seroprevalence of MSP119 can distinguish
between transmission intensities in low versus high malaria transmission areas or
periods (Figure 2). When transmission intensity is below 5%, parasite prevalence is
an inefficient metric for establishing changes in transmission or evaluating the
impact of interventions [23].
Seroprevalence helps to overcome the challenge of subpatent malaria since
microscopy and rapid diagnostic test (RDT) used to measure parasite prevalence
Figure 1.
Relationship between malaria parasite prevalence and antigen specific seroprevalence (adapted from Badu
et al. 2015) [21].
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are less accurate where parasite load is less than 250 parasites per μl [24]. The
profound effect of antimalarial drug intake on parasite density is also not
accounted for in parasite prevalence measurements. With changing parasite load in
the blood in the course of an infection, the accuracy of parasite prevalence is often
unreliable [24].
A study has also indicated that to assess malaria endemicity at varying altitudes,
the most suitable immunological marker to use is MSP -119 [7]. It has been demon-
strated in our studies in Kenya that the prevalence of MSP-1 19 antibody in resi-
dents at the valley bottom was almost two-fold higher than that of the uphill
residents with median total IgG titers indicating a 13-fold difference between the
uphill and valley bottom residents suggesting a higher intensity of malaria
Figure 2.
Seroconversion rate of MSP119 (adapted from Badu et al. 2015 [21].
Figure 3.
Differences in IgG titers among different localities. ***indicates the significance test by Mann-Whitney test,
P value < 0.001 (Uphill n = 401, Valley n = 394). Source: Badu et al. [16].
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transmission in the valley area than the uphill area [17]. This was corroborated by a
related study which revealed that in 82% of all malaria mosquitoes in the highland
aggregated in <300 m area the valley bottom (Guof et al. 2004), [18] This clearly
demonstrates that seroprevalence reflects cumulative exposure and thus, is less
affected by seasonality or unstable transmission due to the longer duration of the
specific antibody response. Age-specific seroprevalence was also used to estimate
seroconversion rates (SCR) as a measure of malaria transmission intensity. Age
seroprevalence curves of the study showed that in low transmission settings, devel-
opment of antibodies is slow and is mainly exhibited by the adult population,
whereas in a high transmission area, much of the population will be seropositive
even at a younger age. Figures 3 and 4 and Table 1 below show the findings of this
experiment.
Another study showed differences in gSG6-P1 specific seroprevalence and anti-
body levels depending on your location. The study observed differences in parasite
prevalence and gSG6-P1 levels across different transmission settings. Thus, salivary
gland gSG6-P1 could be effective in differentiating between vector densities. Again,
the study showed that the risk of exposure to malaria parasite is higher in individ-
uals presenting with anti -gSG6 P1 antibody and that gSG6-P1 seroprevalence is not
cumulative [17].
Figure 4.
Kinetics of the age-dependent antibody prevalence at different altitudes. Phill model: Pt = 0.73(1-e-0.11t),
R2 = 0.95, P<0.001; valley bottom model: Pt = 0.91(1-e-0.39t), R2 = 067, P<0.001. Source: Badu et al. [16].
Parasite prevalence
MSP-119 seroprevalence
Locality (n) Odds Ratio 95% CI P value
Uphill (401) 2.798 [1.018, 7.693] 0.046
Valley (394) 3.167 [1.196, 8.386] 0.020
Total Uphill and Valley (795) 4.282 [2.200, 8.330] < 0.001
Table 1.
Showing the association between MSP-119 seroprevalence with plasmodium parasite prevalence at the
different localities. Source: Badu et al. (2012).
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Age trends of gSG6-P1 is influenced by the differences in the transmission
intensity and thus, children had higher responses to whole salivary gSG6 proteins
while adults had diminished Antibody responses, suggesting desensitisation of the
immune response to the salivary proteins. From all the above, gSG6-P1 measure-
ment shows transient exposure (or seasonal) in a hypoendemic population and
would be more useful even under low malaria transmission period as envisaged in
the pre-elimination and elimination phase of malaria [17].
In a comprehensive study conducted in two malaria endemic western Kenyan
highland areas, 107 proteins of P. falciparum that elicited antibody responses were
identified. Many of these immunogenic proteins had been previously identified in
other studies. Hsp70, ETRAMP10.2, MSP1, and conserved Plasmodium protein
PF3D7. These were the most frequently recognised proteins among the sera groups
studied [25]. Expectedly, more proteins were identified in sera from valley bottom
than sera from hilltop residence. When comparing the breadth of antibody response
to these proteins, the study observed that there was no difference between
We utilise a very simple reversible catalytic conversion model which estimates the rate of
seroconversion from seronegative to seropositive and vice versa with respect to specific study sites. This we
fit with standard maximum likelihood and which assumes a binomial error distribution [7, 16].
Thus seropositive are the percentage individuals whose antibody titers of specific malaria antigens are
above the threshold of unexposed or naive individuals (Defined as three standard deviations above the
value determine for the negative controls).
Reversible catalytic conversion models uses the average yearly rate of conversion to seropositive, λ, and
the average yearly rate of reversion from seropositive to seronegative, ρ [7], The equation is thus fitted for
each study site (uphill dwellers and that of valley bottom dwellers). Thus Pt is the proportion of individuals




1 exp  λ þ ρð Þtð Þð Þ
Where λ is the respective site rate of seroconversion, and ρ is the site specific rate of reversion to
seronegative [7, 16].
Box 1.
Reversible catalytic conversion model.
Figure 5.
Breadth of antibody binding to immunogenic P. falciparum proteins by study sera groups. The number of
proteins considered immunogenic by the study sera (Y axis) is plotted against sera cohorts stratified by age (0–4,
5–14 and > 15 years old), season (wet and dry) and site (hilltop and valley bottom) of sample collection (X
axis). The number of serum samples tested in each sera group is provided in parenthesis above the corresponding
bar (adapted from Baum et al. 2013) [25].
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immunogenic proteins identified during the wet or dry season among valley bottom
residents. However, seasonal variation in protein was observed in hilltop sera.
Between donors below 5 years and those above 5 years, difference between antibody
response was observed (Figure 5). This aligns with surveillance studies that used
clinical cases or parasite prevalence metrics [16, 26].
The study also noted that seroconversion rates differed between hilltop and
valley bottom donors, with lower SCR values recorded for hilltop than in the valley
bottom (Figure 6). Overall, the antigens identified in the study can be used as
protein candidates to sero-survey the intensity of malaria transmission across stable
and unstable transmission areas and compared different age stratifications to give
an overview of the effect of temporal and spatial variations on malaria transmission.
6. Sero-surveilance as for the confirmation of elimination
The development and utilisation of serological tools, especially, the antibody
response to specific malaria antigens has a great potential to support malaria elim-
ination agenda. A recent study [14] has identified about five priority areas in which
this approached could be utilised to support the malaria elimination agenda. Among
these, the confirmation of malaria elimination can be a practical benefit. “Certifica-
tion of malaria elimination is the official recognition by WHO of a country’s
Figure 6.
Whisker box plot of seroconversion rate (SCR) values of immunogenic polypeptides of P. falciparum for the
hilltop and valley bottom sites. The SCR of 98 immunogenic polypeptides for which paired values were
calculated (Y axis) is plotted against the site of serum sample collection (X axis). The lower and upper edges of
the box indicate the first and the third quartiles, the line in the middle represents the median. The 1.5X
interquartile range is indicated by the vertical line outside the boxes. Outlying values are indicated by dots
outside boxes (adapted from Baum et al. 2013) [25].
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malaria-free status”. WHO may grant this recognition to a country only when it can
prove beyond reasonable doubt, that the indigenous malaria transmission of all
human parasites has been interrupted across the whole country for at least three
consecutive years. Not only that but the country also has “a fully functional sur-
veillance and response system that can prevent re-establishment of local transmis-
sion” [27]. Practically, antibodies to malaria antigens are sensitive biomarkers of
population-level malaria exposure and can be used among other things to confirm
malaria elimination, and monitor re-emergence of malaria [28]. Specific anti
malaria antibodies such as MSP119 and AMA that tend to accumulate in the popula-
tion can be used to confirm malaria elimination in children born in the last three
years. When antibody response in children born in the last three years are
undetectable across all subnational sentinel sites, this will be a good indication of
the confirmation of the malaria elimination.
7. Sero-surveilance for monitoring recent exposure
and the impact of interventions
Reliable serological markers of recent malaria exposure could dramatically
improve current surveillance methods by allowing for accurate estimates of infec-
tion incidence from limited data. According to Greenhouse et al. [14], Sero-
surveilance could be implemented in two scenarios settings: 1) when new tools are
being deployed for the first time; and 2) regularly to evaluate the success of such
tools during implementation.
For the purpose of regular evaluation of intervention tools antibodies with
relatively short half life will be more useful. Yman et al. 2016, studied We IgG
antibody responses to over one hundred 111 malaria antigens in a longitudinal
cohort of travellers who did not have a second express following heir initial expo-
sure. They identified five serological markers (GAMA, MSP1, MSPDBL1 C- and N-
terminal, and PfSEA1) which could detect exposure within the previous 3-months
with >80% sensitivity and specificity. Others (Kerkhof et al. 2016) have studied
through several cross-sectional studies among 8439 participants have demonstrated
that Plasmodium falciparum, antibodies against LSA3.RE, GLURP and Pf.GLURP.R2
are capable of detecting exposure range of 6–8 months. The quest for standard
antigenes or peptides as well as standard technologies that will ensure smooth
implementation and comparable results across the world is a subject of intense
research currently ongoing.
8. Conclusion
Currently, the utility of sero-surveilance in the support of malaria elimination
(measuring transmission intensity, assessing the impact evaluation, confirmation of
elimination and prevention of re-introduction) have moved beyond the prove of
principle. However, full implementation is hampered by the current requirement
for expensive high-throughput technologies for specimen storage and functioning
assays, which are largely not available in many malaria-endemic communities.
Therefore, governments and research programs should critically analyse the value
being added by antibody tests before considering using it to complement other
metrics [14, 28].
In their current state, sero-surveillance tools can only be performed by techni-
cians who are well trained on the use of antibody detecting equipment. However,
surveillance studies are often carried out by field workers who might lack the
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adequate knowledge and training needed to perform antibody tests. As such, it is
very important that antibody detecting tools are easy to use, with test results being
easy to interpret [14, 29]. This will ensure the generation of data that can easily be
analysed to translate to action implementation.
The integration of seroprevalence as a malaria surveillance metric in endemic
communities will require the understanding of stakeholders in malaria control and
eradication at the local, national, and global level. This involves engaging and
sensitising local communities, governmental and non-governmental organisations,
research bodies and donor agencies on the need for sero-surveillance as a function
of malaria exposure.
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